Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

A woman's diabetes improved after removing ovarian tumors that caused high testosterone levels.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

Many Iraqi women with hirsutism also have hypothyroidism and acne.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

The man's fatigue and erectile dysfunction were improved by treating his obesity-related low testosterone without needing testosterone replacement.

Androgen levels do not determine the type of PCOS symptoms in young females.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride reduces hair growth better, but spironolactone has more side effects.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.